EUROPE 2016 Paris, France | 9-11 May 2016 | Marriott Rive Gauche Hotel


The CMC Strategy Forums focus on relevant CMC issues throughout the lifecycle of a biological product; and thereby, foster collaborative technical and regulatory interactions.


Forum Co-chairs: Alistair Kippen, Ipsen Limited, United Kingdom Nanna Aaby Kruse,


Danish Medicines Agency, Denmark Jolanda Westerlaken, UCB Canada Inc.


Regulation of Biopharmaceutical Products: Regulatory Perspectives


ICH Q12 Update:


Established Conditions / Approved Matters ICH Q12 Update:


Post-approval Change Management Protocols


Innovative Approaches: Tools and Technology Combination Trials and Combination Products Continuous Process Verification


For program updates, hotel and registration information scan the QR code or visit www.casss.org.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52